OTCMKTS:BICX

Biocorrx Stock Insider Trading

Healthcare > Medical - Care Facilities

Buy BICX

*Your capital is at risk

$0.378

+0.0475 (+14.39%)

At Close: Jun 02, 2026

BioCorRx Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 6.23M and sold 0 BICX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	100.00
● Buy	6.23M shares
● Sell	0 shares
100% Buy Activity Weak Negative Correlation
No Significant Signals No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date	Type	Person	Role	Amount
Sep 29, 2023 Buy	Common Stock, par value $0.001 A-Award	Galligan Joseph J	Director	2 858 Value: $0
Sep 29, 2023 Buy	Common Stock, par value $0.001 A-Award	Galligan Joseph J	Director	2 858 Value: $0
Sep 29, 2023 Buy	Common Stock, par value $0.001 A-Award	Emry Kent Director	Director	2 858 Value: $0
Sep 29, 2023 Buy	Common Stock, par value $0.001 A-Award	Murthy Harsha Director	Director	2 858 Value: $0
Sep 29, 2023 Buy	Common Stock, par value $0.001 A-Award	Ingargiola Luisa Director	Director	2 858 Value: $0
Sep 29, 2023 Buy	Common Stock, par value $0.001 A-Award	Lucido Louis C.	Director	2 858 Value: $0
Sep 29, 2023 Buy	Stock Option A-Award	Granier Brady James President	CEO / President	8 574 Value: $15.0K
Sep 29, 2023 Buy	Common Stock, par value $0.001 A-Award	Felix Lourdes CEO And CFO	CEO / President	2 858 Value: $0
Sep 29, 2023 Buy	Common Stock, par value $0.001 A-Award	Felix Lourdes CEO And CFO	CEO / President	2 858 Value: $0
Sep 29, 2023 Buy	Stock Option A-Award	Granier Brady James President	CEO / President	8 574 Value: $15.0K
Sep 29, 2023 Buy	Common Stock, par value $0.001 A-Award	Lucido Louis C.	Director	2 858 Value: $0
Sep 29, 2023 Buy	Common Stock, par value $0.001 A-Award	Ingargiola Luisa Director	Director	2 858 Value: $0
Sep 29, 2023 Buy	Common Stock, par value $0.001 A-Award	Murthy Harsha Director	Director	2 858 Value: $0
Jun 30, 2023 Buy	Common Stock, par value $0.001 A-Award	Galligan Joseph J	Director	2 891 Value: $0
Jun 30, 2023 Buy	Common Stock, par value $0.001 A-Award	Galligan Joseph J	Director	2 891 Value: $0
Jun 30, 2023 Buy	Common Stock, par value $0.001 A-Award	Emry Kent Director	Director	2 891 Value: $0
Mar 31, 2023 Buy	Common Stock, par value $0.001 A-Award	Galligan Joseph J	Director	2 824 Value: $0
Mar 31, 2023 Buy	Common Stock, par value $0.001 A-Award	Galligan Joseph J	Director	2 824 Value: $0
Mar 31, 2023 Buy	Common Stock, par value $0.001 A-Award	Emry Kent Director	Director	2 824 Value: $0
Mar 29, 2023 Buy	Common Stock, par value $0.001 P-Purchase	Galligan Joseph J	Director	171 296 Value: $299.8K
Mar 29, 2023 Buy	Common Stock, par value $0.001 P-Purchase	Galligan Joseph J	Director	171 296 Value: $299.8K
Dec 30, 2022 Buy	Common Stock, par value $0.001 A-Award	Galligan Joseph J	Director	5 319 Value: $0
Dec 30, 2022 Buy	Common Stock, par value $0.001 A-Award	Galligan Joseph J	Director	5 319 Value: $0
Sep 30, 2022 Buy	Common Stock, par value $0.001 A-Award	Galligan Joseph J	Director	2 450 Value: $0
Sep 30, 2022 Buy	Common Stock, par value $0.001 A-Award	Galligan Joseph J	Director	2 450 Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT BIOCORRX INC

BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to...

Read Full Profile Here